Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC Shares Outstanding 2010-2025 | AMRX

AMNEAL PHARMACEUTICALS, INC shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
AMNEAL PHARMACEUTICALS, INC Annual Shares Outstanding
(Millions of Shares)
2024 309
2023 176
2022 151
2021 152
2020 149
2019 132
2018 127
2017 0
2016 0
2015 72
2014 71
2013 69
2012 68
2011 67
2010 66
2009 61
AMNEAL PHARMACEUTICALS, INC Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 324
2024-12-31 309
2024-09-30 310
2024-06-30 319
2024-03-31 307
2023-12-31 176
2023-09-30 160
2023-06-30 155
2023-03-31 152
2022-12-31 151
2022-09-30 151
2022-06-30 151
2022-03-31 150
2021-12-31 152
2021-09-30 149
2021-06-30 152
2021-03-31 151
2020-12-31 149
2020-09-30 148
2020-06-30 147
2020-03-31 148
2019-12-31 132
2019-09-30 131
2019-06-30 128
2019-03-31 128
2018-12-31 127
2018-09-30 128
2018-06-30 127
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31 72
2016-12-31
2016-09-30 71
2016-06-30 71
2016-03-31 71
2015-12-31 72
2015-09-30 73
2015-06-30 69
2015-03-31 69
2014-12-31 71
2014-09-30 71
2014-06-30 70
2014-03-31 70
2013-12-31 69
2013-09-30 67
2013-06-30 68
2013-03-31 68
2012-12-31 68
2012-09-30 68
2012-06-30 68
2012-03-31 68
2011-12-31 67
2011-09-30 67
2011-06-30 68
2011-03-31 67
2010-12-31 66
2010-09-30 65
2010-06-30 66
2010-03-31 64
2009-12-31 62
2009-09-30 61
2009-06-30 61
2009-03-31 60
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.260B $2.794B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.303B 32.00
Zoetis (ZTS) United States $75.058B 28.00
Daiichi Sankyo, - (DSNKY) Japan $49.349B 25.11
Takeda Pharmaceutical (TAK) Japan $47.824B 9.51
Sandoz Group AG (SDZNY) Switzerland $22.858B 0.00
Merck (MKKGY) Germany $17.228B 12.62
United Therapeutics (UTHR) United States $14.613B 12.93
Summit Therapeutics (SMMT) United States $14.527B 0.00
Shionogi (SGIOY) Japan $14.292B 14.32
Neurocrine Biosciences (NBIX) United States $12.323B 42.21
IPSEN (IPSEY) France $10.209B 0.00
Orion OYJ (ORINY) Finland $9.913B 26.81
Corcept Therapeutics (CORT) United States $7.421B 60.33
Stevanato Group S.p.A (STVN) Italy $6.772B 41.41
Madrigal Pharmaceuticals (MDGL) United States $6.202B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.810B 0.00
Ionis Pharmaceuticals (IONS) United States $5.588B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.882B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.085B 10.81
Crinetics Pharmaceuticals (CRNX) United States $3.008B 0.00
Hypermarcas (HYPMY) Brazil $2.882B 18.96
BioCryst Pharmaceuticals (BCRX) United States $2.310B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.177B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.996B 0.00
Indivior (INDV) United States $1.885B 7.99
Centessa Pharmaceuticals (CNTA) United Kingdom $1.673B 0.00
Dyne Therapeutics (DYN) United States $1.524B 0.00
Evotec AG (EVO) Germany $1.456B 0.00
Guardian Pharmacy Services (GRDN) United States $1.361B 0.00
ARS Pharmaceuticals (SPRY) United States $1.357B 0.00
Ocular Therapeutix (OCUL) United States $1.335B 0.00
Enliven Therapeutics (ELVN) United States $1.094B 0.00
Harrow (HROW) United States $1.083B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.079B 21.59
Akebia Therapeutics (AKBA) United States $0.956B 0.00
Collegium Pharmaceutical (COLL) United States $0.945B 5.10
Avadel Pharmaceuticals (AVDL) Ireland $0.901B 0.00
Ardelyx (ARDX) United States $0.883B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Xeris Biopharma Holdings (XERS) United States $0.693B 0.00
KalVista Pharmaceuticals (KALV) United States $0.673B 0.00
Xencor (XNCR) United States $0.648B 0.00
AleAnna (ANNA) United States $0.630B 0.00
Elite Pharmaceuticals (ELTP) United States $0.598B 0.00
USANA Health Sciences (USNA) United States $0.554B 12.04
Relay Therapeutics (RLAY) United States $0.554B 0.00
Theravance Biopharma (TBPH) United States $0.551B 0.00
Regulus Therapeutics (RGLS) United States $0.550B 0.00
Bioventus (BVS) United States $0.536B 13.60
Zevra Therapeutics (ZVRA) United States $0.489B 0.00
Tourmaline Bio (TRML) United States $0.481B 0.00
Verve Therapeutics (VERV) United States $0.472B 0.00
Altimmune (ALT) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.439B 9.18
Amylyx Pharmaceuticals (AMLX) United States $0.439B 0.00
Oruka Therapeutics (ORKA) United States $0.437B 0.00
Savara (SVRA) United States $0.430B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.367B 9.92
Organogenesis (ORGO) United States $0.363B 0.00
Aquestive Therapeutics (AQST) United States $0.339B 0.00
Liminatus Pharma (LIMN) United States $0.331B 0.00
Heron Therapeutics (HRTX) United States $0.311B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.285B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 24.42
MediWound (MDWD) Israel $0.235B 0.00
ProKidney (PROK) United States $0.231B 0.00
Esperion Therapeutics (ESPR) United States $0.222B 0.00
Nanobiotix S.A (NBTX) France $0.214B 0.00
Lyell Immunopharma (LYEL) United States $0.199B 0.00
4D Molecular Therapeutics (FDMT) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.174B 0.00
Journey Medical (DERM) United States $0.174B 0.00
OmniAb (OABI) United States $0.171B 0.00
Profound Medical (PROF) Canada $0.166B 0.00
Larimar Therapeutics (LRMR) United States $0.157B 0.00
Avita Medical (RCEL) United States $0.157B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.148B 0.00
Inhibikase Therapeutics (IKT) United States $0.147B 0.00
Wellgistics Health (WGRX) United States $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.139B 0.00
Achieve Life Sciences (ACHV) Canada $0.133B 0.00
Protara Therapeutics (TARA) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Korro Bio (KRRO) United States $0.112B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Inotiv (NOTV) United States $0.103B 0.00
Lexeo Therapeutics (LXEO) United States $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.097B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Unicycive Therapeutics (UNCY) United States $0.093B 0.00
VAXART, INC (VXRT) United States $0.092B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.088B 14.50
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 61.44
Galectin Therapeutics (GALT) United States $0.081B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.048B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Lyra Therapeutics (LYRA) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.26
Scienture Holdings (SCNX) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00